September 16, 2022
machineMD @ Dreiländertagung 2022
Join the machineMD team on Stand 1 as orthoptists and ophthalmologists from Germany, Austria and Switzerland come together on September 16th and 17th, 2022, in Zurich.
A multi-functional device for early diagnosis of brain disease such as tumors, multiple sclerosis, and stroke through the analysis of eye and pupil movements.
The NeurOphthalmoscope is a medical device for early diagnosis of brain diseases such as tumors, multiple sclerosis, and stroke.
The device measures eye and pupil movements induced by visual stimuli. Eight neuro-ophthalmic examinations, including pupillary function and visual field measurements are combined in one multi-functional device.
machineMD is a Swiss medtech startup with close ties to the University Hospital in Bern.
We develop the NeurOphthalmoscope, a diagnostic device for an automated, objective and quantifiable analysis of brain functions related to the visual system.
machineMD’s vision is to become the leading provider for detecting loss of brain function.
We are an experienced team of senior professionals with expertise in business development, ophthalmology and neurology, research and development and regulatory- and clinical affairs.
CEO
Prof. Dr. Dr.
Medical Director
Dr.
Regulatory Affairs
Dr.
Head of Technology
Head of Research and Development
Head of Software Engineering
Senior Requirements Engineer
Head of Commercial Strategy
Business Development Consultant
Senior Communications Specialist
HR & Finance Assistant
For all enquiries, please contact us using the form below. We are looking forward to hearing from you.
Sign up to receive updates from machineMD delivered to your inbox.
machineMD is supported by companies and institutions in the field of medtech and innovation.
